Wan Shan Chen's Sale of Belite Bio, Inc Common Stock

Wan Shan Chen, an affiliate of Belite Bio, Inc, has filed a Form 144 notice indicating the intent to sell 1,050 shares of common stock acquired through a Non-Qualified Stock Award on December 29, 2020. The sale is expected to occur around October 16, 2025, with an aggregate market value of $89,250. Additionally, Chen recently sold 1,050 shares on October 13, 2025, for $84,000. The transactions are facilitated by J.P. Morgan Securities LLC, acting as agent and attorney-in-fact for Chen. The filing highlights the ongoing financial activities of key personnel within Belite Bio, Inc.